4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
主营:主营:癌症、免疫、炎症、代谢疾病(糖尿病、肥胖)、干细胞和神经退行性疾病等领域
咨询热线电话
4000-520-616
当前位置: 首页 > 产品中心 > Other_reagents > Adipogen/L-NMMA . monoacetate/AG-CR1-3578-M025/25 mg
商品详细Adipogen/L-NMMA . monoacetate/AG-CR1-3578-M025/25 mg
Adipogen/L-NMMA . monoacetate/AG-CR1-3578-M025/25 mg
Adipogen/L-NMMA . monoacetate/AG-CR1-3578-M025/25 mg
商品编号: AG-CR1-3578-M025
品牌: Adipogen Inc
市场价: ¥1100.00
美元价: 660.00
产地: 美国(厂家直采)
公司:
产品分类: 其他试剂
公司分类: Other_reagents
联系Q Q: 3392242852
电话号码: 4000-520-616
电子邮箱: info@ebiomall.com
商品介绍
MoreInformation
ProductDetails
SynonymsNG-Monomethyl-L-arginine.monoacetate
ProductTypeChemical
Properties
FormulaC7H16N4O2.CH3COOH
MW188.2.60.1
MerckIndex14:6022
CAS53308-83-1
RTECSRM2982000
PurityChemicals≥99%(TLC)
AppearanceWhitetooff-whitesolid.
SolubilitySolubleinwater,ethanol,methanolorDMSO.
InChiKeyIKPNWIGTWUZCKM-JEDNCBNOBD
ShippingandHandling
ShippingAMBIENT
ShortTermStorage+4°C
LongTermStorage-20°C
HandlingAdviceKeepcoolanddry.
Use/StABIlityStableforatleast2yearsafterreceiptwhenstoredat-20°C.
Documents
MSDSDownloadPDF
ProductSpecificationSheet
DatasheetDownloadPDF
  • Endothelium-derivedrelaxingfactorinhibitor.InhibitsthegenerationofNOfromarginine.
  • Competitive,irreversIBLenon-selectiveinhibitorofallthreeNOSI,II,andIIIisoforms(eNOS,iNOSandnNOS).
  • Inhibitsthesynthesisofnitricoxide(NO)inadose-dependentandenantiospecificfashion.
  • UsefultooltostudytheroleandtheeffectsofNOincardiovascularandgastrointestinaldisorders,hypertension,diabetes,septicshock,inflammation,infection,strokeandneurodegenerativedisorders.
ProductReferences
  1. Identificationofarginineasaprecursorofendothelium-derivedrelaxingfactor:I.Sakuma,etal.;PNAS85,8664(1988)
  2. NG-methylarginine,aninhibitorofendothelium-derivednitricoxidesynthesis,isapotentpressoragentintheguineapig:doesnitricoxideregulatebloodpressureinvivo?:K.Aisaka,etal.;BBRC160,881(1989)
  3. AspecificinhibitorofnitricoxideformationfromL-arginineattenuatesendothelium-dependentrelaxation:D.D.Rees,etal.;Br.J.Pharmacol.96,418(1989)
  4. Characterizationofthreeinhibitorsofendothelialnitricoxidesynthaseinvitroandinvivo:D.D.Rees,etal.;Br.J.Pharmacol.101,746(1990)
  5. Roleofendothelium-formednitricoxideonvascularresponses:J.MarinJ&C.F.Sanchez-Ferrer;Gen.Pharmacol.21,575(1990)
  6. InactivationofmacrophagenitricoxidesynthaseactivitybyN(G)-methyl-L-arginine:N.M.Olken,etal.;BBRC177,828(1991)
  7. Nitricoxide:anendogenousmodulatorofleukocyteadhesion:P.Kubes,etal.;PNAS88,4651(1991)
  8. Macrophagenitricoxidemediatesimmunosuppressionininfectiousinflammation:T.K.Eisenstein,etal.;ImmunoBIOLOGy191,493(1994)(Review)
  9. N-nitro-L-arginineandN-monomethyl-L-arginineexhibitadifferentialpatternofinactivationtowardthethreenitricoxidesynthases:D.W.Reif&C.A.McCreedy;Arch.Biochem.Biophys.320,170(1995)
  10. Celldeath,survivalandproliferationinTetrahymenaThermophila.Effectsofinsulin,sodiumnitroprusside,8-BromocyclicGMP,NG-methyl-L-arginineandmethyleneblue:S.T.Christensen;CellBiol.Int.20,653(1996)(Review)
  11. Nitricoxidesynthaseinhibitors:Aminoacids.O.W.Griffith&R.G.Kilbourn;MethodsEnzymol.268,375(1996)
  12. Selectiveinhibitorsofneuronalnitricoxidesynthase-isnoNOSreallygoodNOSforthenervoussystem?P.K.Moore&R.L.Handy;TIPS18,204(1997)(Review)
  13. Asymmetricdimethylarginine(ADMA)andotherendogenousnitricoxidesynthase(NOS)inhibitorsasanimportantcauseofvascularinsulinresistance:K.Toutouzas;Horm.Metab.Res.40,655(2008)(Review)
  14. InsulinresistanceafterhypertensioninducedbythenitricoxidesynthesisinhibitorL-NMMAinrats:A.D.Baron;Am.J.Physiol.269,E709(1995)
  15. TheNOsynthaseinhibitorsL-NameandL-NMMA,butnotL-arginine,blockthemammaliannicotinicacetylcholinereceptorchannel:MScheller;Toxicol.Lett.100-101,109(1998)
  16. InductionofapoptosisbyL-NMMA,viaFKHRL1/ROCKpathwayinhumangastriccancercells:Y.Z.Wang&Z.Q.Feng;Biomed.Environ.Sci.19,285(2006)
品牌介绍
Adipogen公司由三个子公司组成,分别是Adipogen,Inc.(韩国),AdipogenSA(瑞士)和 AdipogenCorporation(美国圣地亚哥)。总部设在美国,运营总部在瑞士利斯塔尔。Adipogen公司专门从事生命科学研究试剂的开发,如癌症、免疫、炎症、代谢疾病(糖尿病、肥胖)、干细胞和神经退行性疾病等领域。其重点关注开发创新优质的ELISA试剂盒。另外,也可提供抗体和蛋白产品,Adipogen拥有自己的化学实验室,致力于开发创新型小分子化合物。